AS Latvijas Juras medicinas centrs (UOM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.098x

Based on the latest financial reports, AS Latvijas Juras medicinas centrs (UOM) has a cash flow conversion efficiency ratio of -0.098x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-622.30K ≈ $-727.54K USD) by net assets (€6.33 Million ≈ $7.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AS Latvijas Juras medicinas centrs (UOM) balance sheet quality index to measure how much of total assets are equity-financed.

AS Latvijas Juras medicinas centrs - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how AS Latvijas Juras medicinas centrs's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AS Latvijas Juras medicinas centrs cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

AS Latvijas Juras medicinas centrs Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AS Latvijas Juras medicinas centrs ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Rebosis
JSE:REB
-0.010x
Pantera Lithium Ltd
AU:PFE
-0.028x
GENINCODE PLC LS -01
F:9PL
N/A
Upsellon Brands Holdings Ltd
TA:UPSL
-0.117x
Henderson Far East Income Ltd
LSE:HFEL
0.025x
USWE Sports AB
ST:USWE
-0.007x
XP Power Ltd
LSE:XPP
0.178x
Alfa Financial Software Holdings PLC
LSE:ALFA
0.350x

Annual Cash Flow Conversion Efficiency for AS Latvijas Juras medicinas centrs (2015–2025)

The table below shows the annual cash flow conversion efficiency of AS Latvijas Juras medicinas centrs from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see UOM company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €6.33 Million
≈ $7.40 Million
€-17.28K
≈ $-20.20K
-0.003x -102.78%
2024-12-31 €6.17 Million
≈ $7.21 Million
€605.02K
≈ $707.33K
0.098x -68.18%
2023-12-31 €6.20 Million
≈ $7.25 Million
€1.91 Million
≈ $2.24 Million
0.308x +91.95%
2022-12-31 €6.81 Million
≈ $7.96 Million
€1.09 Million
≈ $1.28 Million
0.161x +143.58%
2021-12-31 €6.34 Million
≈ $7.41 Million
€418.24K
≈ $488.96K
0.066x -50.34%
2020-12-31 €5.52 Million
≈ $6.45 Million
€732.71K
≈ $856.61K
0.133x +77.02%
2019-12-31 €5.50 Million
≈ $6.43 Million
€412.86K
≈ $482.67K
0.075x -30.76%
2018-12-31 €5.53 Million
≈ $6.47 Million
€599.57K
≈ $700.96K
0.108x +34.95%
2017-12-31 €5.96 Million
≈ $6.96 Million
€478.41K
≈ $559.31K
0.080x +33.84%
2016-12-31 €6.97 Million
≈ $8.15 Million
€418.49K
≈ $489.26K
0.060x +17.88%
2015-12-31 €7.12 Million
≈ $8.32 Million
€362.36K
≈ $423.63K
0.051x --

About AS Latvijas Juras medicinas centrs

MU:UOM Germany Medical Care Facilities
Market Cap
$6.92 Million
€5.92 Million EUR
Market Cap Rank
#28230 Global
#2431 in Germany
Share Price
€7.40
Change (1 day)
-5.73%
52-Week Range
€6.40 - €9.20
All Time High
€12.98
About

AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more